Overview

Safety and Efficacy of Low Dosage of Terazosin in Subjects Undergoing Carotid Artery Stenting

Status:
Unknown status
Trial end date:
2019-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of low dosage of Terazosin in Carotid Artery Stenting
Phase:
Phase 2
Details
Lead Sponsor:
Capital Medical University
Collaborators:
Beijing Anzhen Hospital
The Luhe Teaching Hospital of the Capital Medical University
Treatments:
Prazosin
Terazosin